CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
Original article

Corporate report: MHRA-NICE Real-World Evidence Scientific Dialogue

RegulatoryNeutral
AI Analysis

Summary

MHRA and NICE have established a collaborative programme to support decision-making using real-world evidence across the product lifecycle for regulatory and HTA evaluations.

Importance:2/10
Sentiment:
0.00
real-world evidenceregulatory pathwayhealth technology assessmentscientific dialogue
Related Companies

Read the original article

Published by MHRA (UK) on September 4, 2026 10:18 AM

Read Original